Markersen sygehus ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 10.3% 12.7% 19.4%  
Credit score (0-100)  0 0 22 17 6  
Credit rating  N/A N/A BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 137 588 502  
EBITDA  0.0 0.0 11.7 -85.2 116  
EBIT  0.0 0.0 11.7 -85.2 116  
Pre-tax profit (PTP)  0.0 0.0 11.5 -87.7 113.8  
Net earnings  0.0 0.0 9.0 -68.8 88.5  
Pre-tax profit without non-rec. items  0.0 0.0 11.5 -87.7 114  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 49.0 -19.8 68.7  
Interest-bearing liabilities  0.0 0.0 0.0 36.9 37.6  
Balance sheet total (assets)  0.0 0.0 89.3 79.8 144  

Net Debt  0.0 0.0 -40.9 32.5 37.6  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 137 588 502  
Gross profit growth  0.0% 0.0% 0.0% 329.9% -14.5%  
Employees  0 0 1 2 1  
Employee growth %  0.0% 0.0% 0.0% 100.0% -50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 89 80 144  
Balance sheet change%  0.0% 0.0% 0.0% -10.7% 80.0%  
Added value  0.0 0.0 11.7 -85.2 115.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 8.6% -14.5% 23.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 13.1% -90.2% 95.2%  
ROI %  0.0% 0.0% 23.9% -198.5% 161.6%  
ROE %  0.0% 0.0% 18.3% -106.8% 119.2%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 54.8% -19.9% 47.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -349.4% -38.1% 32.5%  
Gearing %  0.0% 0.0% 0.0% -186.0% 54.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 13.4% 5.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 2.2 0.8 1.9  
Current Ratio  0.0 0.0 2.2 0.8 1.9  
Cash and cash equivalent  0.0 0.0 40.9 4.4 0.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 49.0 -19.8 68.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 12 -43 116  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 12 -43 116  
EBIT / employee  0 0 12 -43 116  
Net earnings / employee  0 0 9 -34 89